Skip to main content

Animations

MJFF Publications

6241 - 6250 of 8818 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2019
  • 2020
  • 2019
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-019-0556-3
    Citation Count: 171
  • Summary Details
    OPEN
    Title: Association of specific biotypes in patients with Parkinson disease and disease progression
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000010498
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/jnnp-2019-321794
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-59414-4
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2020.00033
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Subcortical Intermittent Theta-Burst Stimulation (iTBS) Increases Theta-Power in Dorsolateral Prefrontal Cortex (DLPFC)
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00041
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2020/9716317
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-020-0401-2
    Citation Count: 98
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.